[go: up one dir, main page]

WO2005040398A3 - Methods for preserving nucleated mammalian cells - Google Patents

Methods for preserving nucleated mammalian cells Download PDF

Info

Publication number
WO2005040398A3
WO2005040398A3 PCT/US2004/034605 US2004034605W WO2005040398A3 WO 2005040398 A3 WO2005040398 A3 WO 2005040398A3 US 2004034605 W US2004034605 W US 2004034605W WO 2005040398 A3 WO2005040398 A3 WO 2005040398A3
Authority
WO
WIPO (PCT)
Prior art keywords
mammalian cells
methods
cells
nucleated mammalian
preserving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/034605
Other languages
French (fr)
Other versions
WO2005040398A9 (en
WO2005040398A2 (en
Inventor
John H Crowe
Fern Tablin
Ann E Oliver
Kamran Jamil
Xiaocui Ma
James S Clegg
Willem Wolkers
Thurein Htoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/722,154 external-priority patent/US20050112686A1/en
Priority claimed from US10/721,678 external-priority patent/US20040185524A1/en
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Priority to US10/575,832 priority Critical patent/US20070026377A1/en
Publication of WO2005040398A2 publication Critical patent/WO2005040398A2/en
Publication of WO2005040398A9 publication Critical patent/WO2005040398A9/en
Publication of WO2005040398A3 publication Critical patent/WO2005040398A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Methods and compositions are provided for increasing the survival of nucleated mammalian cells following drying and rehydration. The methods include introducing a disaccharide such as trehalose into said cells, optionally including heat shock proteins, apoptosis inhibitors, and arbutin, drying said cells, and rehydrating them. The invention further provides nucleated mammalian cells that have increased capacity to survive, divide and, in some cases, differentiate, following drying and rehydration. The cells comprise a disaccharide and one or more of the following: a heat shock protein, an apoptosis inhibitor, and arbutin.
PCT/US2004/034605 2000-02-10 2004-10-18 Methods for preserving nucleated mammalian cells Ceased WO2005040398A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/575,832 US20070026377A1 (en) 2000-02-10 2004-10-18 Methods for preserving nucleated mammalian cells

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US68690403A 2003-10-16 2003-10-16
US10/686,904 2003-10-16
US72155703A 2003-11-25 2003-11-25
US10/722,154 2003-11-25
US10/721,557 2003-11-25
US10/722,154 US20050112686A1 (en) 2003-11-25 2003-11-25 Method for introducing molecules into biological samples
US10/721,678 2003-11-25
US10/721,678 US20040185524A1 (en) 2000-02-10 2003-11-25 Biological samples and method for increasing survival of biological samples

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/721,678 Continuation US20040185524A1 (en) 2000-02-10 2003-11-25 Biological samples and method for increasing survival of biological samples

Publications (3)

Publication Number Publication Date
WO2005040398A2 WO2005040398A2 (en) 2005-05-06
WO2005040398A9 WO2005040398A9 (en) 2005-08-25
WO2005040398A3 true WO2005040398A3 (en) 2006-01-26

Family

ID=34528256

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/034605 Ceased WO2005040398A2 (en) 2000-02-10 2004-10-18 Methods for preserving nucleated mammalian cells

Country Status (1)

Country Link
WO (1) WO2005040398A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090221056A1 (en) 2005-11-30 2009-09-03 Petrovick Martha S Pathogen-Detecting Cell Preservation Systems
US8465733B2 (en) * 2007-11-02 2013-06-18 Jcr Pharmaceuticals Co., Ltd. Pharmaceutical composition containing human mesenchymal stem cell
CN102487938B (en) * 2011-11-15 2014-04-02 青岛大学医学院附属医院 Cryopreservation method for protecting cell junction
BR102014002362A8 (en) * 2014-01-30 2018-04-17 Uniao Brasileira De Educacao E Assistencia Mantenedora Da Puc Rs method of immunomodulation and / or preservation of ex vivo organs, compositions, process and uses
WO2017160835A1 (en) 2016-03-14 2017-09-21 The Regents Of The University Of Michigan A surface tension mediated lyo-processing technique for preservation of biologics
CN113481207B (en) * 2021-07-15 2023-04-07 西南大学 Essential gene Bmtret1 for silkworm egg diapause and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827741A (en) * 1996-11-19 1998-10-27 The Regents Of The University Of California Cryopreservation of human adult and fetal pancreatic cells and human platelets
US6127177A (en) * 1998-09-11 2000-10-03 Massachusetts Institute Of Technology Controlled reversible poration for preservation of biological materials
US20020076445A1 (en) * 2000-02-10 2002-06-20 Crowe John H. Eukaryotic cells and method for preserving cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827741A (en) * 1996-11-19 1998-10-27 The Regents Of The University Of California Cryopreservation of human adult and fetal pancreatic cells and human platelets
US6127177A (en) * 1998-09-11 2000-10-03 Massachusetts Institute Of Technology Controlled reversible poration for preservation of biological materials
US20020076445A1 (en) * 2000-02-10 2002-06-20 Crowe John H. Eukaryotic cells and method for preserving cells

Also Published As

Publication number Publication date
WO2005040398A9 (en) 2005-08-25
WO2005040398A2 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
BRPI0607203A2 (en) isolated anti-cd30 antibody, host cell, methods for inhibiting cd30 + cell growth, and use of a defucosylated anti-cd30 antibody
MX2009010492A (en) Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells.
WO2009064486A3 (en) Inhibitors of pim protein kinases, compositions, and methods for treating cancer
MX2010003631A (en) Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes.
WO2002101018A3 (en) Methods for inducing reversible stasis
WO2006124892A3 (en) Modulators of alpha-synuclein toxicity
WO2007067781A3 (en) 9-membered heterobicyclic compounds as inhibitors of protein kinases
TW200510413A (en) Novel pyrrolodihydroisoquinolines
EP1670771A4 (en) Compounds and compositions as protein kinase inhibitors
NO20065084L (en) Interferon-alpha polypeptides and conjugates
MX2020007954A (en) Protein kinase mkk4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death.
WO2001085910A3 (en) Agents that modulate dna-pk activity and methods of use thereof
MX2007004841A (en) Triazoles useful as inhibitors of protein kinases.
WO2007065010A3 (en) Anti-angiogenesis compounds
WO2006024640A3 (en) Triazolophthalazines
NZ785221A (en) Heteroaryl-substituted pyrazolo-pyridine protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
WO2006128455A3 (en) Compounds modifying apoptosis
ATE148468T1 (en) NEW ICE CORE-FORMING MICROORGANISMS
WO2008128050A3 (en) Methods for identification of modulators of carm1 methyl transferase activity
WO2005040398A3 (en) Methods for preserving nucleated mammalian cells
ZA200609637B (en) 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors
WO2009059201A3 (en) Id2 as a target in colorectal carcinoma
WO2006069719A3 (en) Lyophilization of virosomes
WO2007028079A3 (en) Methods of stimulating expansion of hematopoietic stem cells
MX2008001538A (en) 2-aminoaryl pyridines as protein kinases inhibitors.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
COP Corrected version of pamphlet

Free format text: PAGES 1/10-10/10, DRAWINGS, REPLACED BY NEW PAGES 1/10-10/10; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWE Wipo information: entry into national phase

Ref document number: 2007026377

Country of ref document: US

Ref document number: 10575832

Country of ref document: US

122 Ep: pct application non-entry in european phase
WWP Wipo information: published in national office

Ref document number: 10575832

Country of ref document: US